Celldex Therapeutics Total Non Current Liabilities 2011-2026 | CLDX

Annual Total Non Current Liabilities Celldex Therapeutics

2024	2023	2022	2021	2020	2019	2018	2017	2016	2015	2014	2013	2012	2011
-	-	-	-	-	17.3 M	19.1 M	51.5 M	82.7 M	17.2 M	11.9 M	6.95 M	12.1 M	15 M

All numbers in USD currency

Indicator range from annual reports

Maximum	Minimum	Average
82.7 M	6.95 M	26 M

Total Non Current Liabilities of other stocks in the Biotechnology industry

Issuer	Total Non Current Liabilities	Price	% 24h	Market Cap	Country
Biogen BIIB	9.03 B	$ 173.17	0.92 %	$ 25.2 B	USA
MorphoSys AG MOR	40.2 M	-	2.43 %	$ 254 M	Germany
Adagene ADAG	158 M	$ 2.4	-3.61 %	$ 135 M	China
Acorda Therapeutics ACOR	257 M	-	-24.86 %	$ 820 K	USA
BioNTech SE BNTX	341 M	$ 117.62	1.41 %	$ 27.2 B	Germany
Aptorum Group Limited APM	2.21 M	$ 0.98	1.35 %	$ 5.34 M	China
Alterity Therapeutics Limited ATHE	73.6 K	$ 3.67	3.38 %	$ 8.83 B	Australia
Alexion Pharmaceuticals, Inc. ALXN	4.83 B	-	-	$ 40.3 B	USA
Catalyst Biosciences CBIO	981 K	$ 11.66	-8.95 %	$ 768 M	USA
Biophytis SA BPTS	2.02 M	-	-13.47 %	$ 169 M	France
Midatech Pharma plc MTP	110 K	-	-18.52 %	$ 27.3 M	Britain
EyeGate Pharmaceuticals, Inc. EYEG	6.39 M	-	-1.52 %	$ 24.7 M	USA
Akero Therapeutics AKRO	1.52 M	-	-	$ 3.67 B	USA
BioXcel Therapeutics BTAI	1.4 M	$ 1.77	-2.75 %	$ 4.49 M	USA
BioLineRx Ltd. BLRX	8.22 M	$ 3.12	0.59 %	$ 908 M	Israel
Applied Molecular Transport AMTI	106 M	-	-	$ 10.1 M	USA
Cellectis S.A. CLLS	109 M	$ 4.13	-6.56 %	$ 116 M	France
Институт стволовых клеток человека ISKJ	541 M	-	-	-	Russia
Ascendis Pharma A/S ASND	101 M	$ 233.49	-0.81 %	$ 5 B	Danmark
ARCA biopharma ABIO	409 K	-	1052.0 %	$ 415 M	USA
Acasti Pharma ACST	12.2 M	-	4.01 %	$ 150 M	Canada
Arrowhead Pharmaceuticals ARWR	686 M	$ 67.41	0.54 %	$ 9.02 B	USA
Compugen Ltd. CGEN	39.9 M	$ 2.04	-2.39 %	$ 183 M	Israel
Can-Fite BioPharma Ltd. CANF	1.63 M	$ 4.36	-2.46 %	$ 9.49 B	Israel
Aeterna Zentaris AEZS	19.1 M	-	5.93 %	$ 314 M	Canada
AgeX Therapeutics AGE	1.53 M	-	-10.17 %	$ 12.2 K	USA
Aeglea BioTherapeutics AGLE	4.74 M	-	-	$ 1.01 B	USA
Akouos AKUS	12 M	-	0.23 %	$ 488 M	USA
Adaptimmune Therapeutics plc ADAP	23.6 M	-	-15.15 %	$ 60.3 M	Britain
Amphastar Pharmaceuticals AMPH	69.4 M	$ 26.57	2.51 %	$ 1.29 B	USA
Coherus BioSciences CHRS	189 M	$ 2.26	9.7 %	$ 213 M	USA
Amneal Pharmaceuticals AMRX	2.42 B	$ 13.59	1.46 %	$ 4.2 B	USA
AIkido Pharma AIKI	2.29 M	-	1.93 %	$ 17.4 M	USA
Albireo Pharma ALBO	79.1 M	-	-0.23 %	$ 916 M	USA
CureVac N.V. CVAC	112 M	-	-	$ 867 M	Germany
Aptose Biosciences APTO	10.2 M	-	-45.71 %	$ 1.2 M	Canada
Acer Therapeutics ACER	244 K	-	2.71 %	$ 14 M	USA
Aravive ARAV	10.2 M	-	-13.39 %	$ 1.45 M	USA
Alpine Immune Sciences ALPN	15.9 M	-	-	$ 2.17 B	USA
AlloVir ALVR	5.46 M	-	4.14 %	$ 49.1 M	USA
Athira Pharma ATHA	876 K	-	-	$ 269 M	USA
Ampio Pharmaceuticals AMPE	3.53 M	-	-11.43 %	$ 502 K	USA
AVROBIO AVRO	276 K	-	1083.1 %	$ 745 M	USA
Ayala Pharmaceuticals AYLA	553 K	-	-	$ 7.46 M	Israel
Aytu BioScience AYTU	42.1 M	$ 2.75	1.85 %	$ 17.3 M	USA
AstraZeneca PLC AZN	30.8 B	$ 94.24	1.38 %	$ 96.9 B	Britain
Arena Pharmaceuticals ARNA	52.2 M	-	-6.81 %	$ 3.04 B	USA
Brickell Biotech BBI	146 K	-	-5.38 %	$ 6.06 M	USA